Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00260624 · ClinicalTrials.gov registry record · Phase 4
Escitalopram Treatment of Patients With Agitated Dementia
A Phase 4 study, sponsored by University of Rochester.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT00260624 is a Phase 4 study that has completed, run by University of Rochester. The registered enrollment target is 20 participants.
The verdict
NCT00260624, a Phase 4 study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safety and efficacy of escitalopram (Lexapro) using 10 or 20 mg daily in patients with Alzheimer's disease who are also experiencing agitation.
Interventions
- DRUG Escitalopram (Lexapro)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2003-02 |
| Est. Completion | 2006-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00260624
The ClinicalTrials.gov registry entry for NCT00260624 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Escitalopram (Lexapro) is the first listed.
NCT00260624 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00260624 about?
NCT00260624 is a clinical study titled "Escitalopram Treatment of Patients With Agitated Dementia". The purpose of this study is to determine the safety and efficacy of escitalopram (Lexapro) using 10 or 20 mg daily in patients with Alzheimer's disease who are also experiencing agitation.
What is the current status of trial NCT00260624?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2003-02. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00260624?
The interventions under investigation include: Escitalopram (Lexapro) (DRUG).
Who is sponsoring clinical trial NCT00260624?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.